MEDX vs. CNCR ETF Comparison
Comparison of Horizon Kinetics Medical ETF (MEDX) to Loncar Cancer Immunotherapy ETF (CNCR)
MEDX
Horizon Kinetics Medical ETF
MEDX Description
The fund is an actively-managed exchange-traded fund ("ETF") that pursues its investment objective by investing, under normal circumstances, at least 80% of its net assets plus any borrowings for investment purposes in common stocks, convertible securities, warrants and other equity securities having the characteristics of common stocks of U.S. and foreign companies engaged in medical research, pharmaceutical and medical technology industries and related technology industries. The fund is non-diversified.
Grade (RS Rating)
Last Trade
$29.27
Average Daily Volume
512
32
CNCR
Loncar Cancer Immunotherapy ETF
CNCR Description
ETF Series Solutions - Loncar Cancer Immunotherapy ETF is an exchange traded fund launched by ETF Series Solutions. The fund is co-managed by Exchange Traded Concepts, LLC and Vident Investment Advisory, LLC. It invests in public equity markets of the United States. The fund invests in stocks of companies operating in the pharmaceutical or biotechnology sectors, including those companies identified as having a high strategic focus on the development of drugs that harness the body's own immune system to fight cancer. It invests in stocks of companies across all market capitalizations. The fund seeks to replicate the performance of the Loncar Cancer Immunotherapy Index, by investing in stocks of companies as per their weightings in the index. ETF Series Solutions - Loncar Cancer Immunotherapy ETF is domiciled in the United States.Grade (RS Rating)
Last Trade
$14.74
Average Daily Volume
3,771
67
Performance
Period | MEDX | CNCR |
---|---|---|
30 Days | -4.20% | 0.07% |
60 Days | -8.31% | -2.25% |
90 Days | -4.39% | 3.58% |
12 Months | 4.75% | 45.65% |
MEDX Overweight 25 Positions Relative to CNCR
Symbol | Grade | Weight | |
---|---|---|---|
LLY | F | 16.14% | |
ABBV | A | 8.78% | |
AMGN | C | 6.01% | |
NVS | D | 5.98% | |
AZN | F | 5.15% | |
JNJ | D | 4.65% | |
ALNY | C | 4.6% | |
PFE | D | 4.19% | |
ALKS | F | 3.44% | |
BIIB | F | 3.21% | |
CRSP | C | 2.87% | |
IONS | F | 2.78% | |
GSK | F | 2.36% | |
BEAM | F | 1.22% | |
NTLA | F | 1.17% | |
HLN | D | 0.78% | |
GALT | F | 0.77% | |
VNDA | D | 0.67% | |
EDIT | F | 0.54% | |
LTRN | F | 0.53% | |
GEHC | D | 0.48% | |
VTRS | B | 0.24% | |
PACB | C | 0.14% | |
BLUE | F | 0.1% | |
MURA | D | 0.05% |
MEDX Underweight 60 Positions Relative to CNCR
Symbol | Grade | Weight | |
---|---|---|---|
BMEA | D | -1.91% | |
TYRA | F | -1.89% | |
ELVN | B | -1.75% | |
HCM | C | -1.74% | |
ACLX | B | -1.55% | |
MGNX | C | -1.55% | |
YMAB | A | -1.54% | |
AURA | B | -1.54% | |
AUTL | D | -1.51% | |
KPTI | C | -1.5% | |
RVMD | A | -1.47% | |
DAWN | A | -1.42% | |
ARVN | C | -1.42% | |
MRUS | C | -1.41% | |
MRSN | D | -1.41% | |
JANX | A | -1.4% | |
EXEL | A | -1.39% | |
RPTX | C | -1.39% | |
RCUS | F | -1.38% | |
IGMS | B | -1.37% | |
SNDX | F | -1.37% | |
KYMR | C | -1.36% | |
XNCR | A | -1.35% | |
IOVA | B | -1.35% | |
GNLX | C | -1.32% | |
BPMC | C | -1.32% | |
ACRV | B | -1.32% | |
IMCR | F | -1.31% | |
NRIX | B | -1.31% | |
ACET | F | -1.3% | |
CRBU | D | -1.28% | |
STRO | D | -1.28% | |
RXRX | F | -1.28% | |
PGEN | F | -1.27% | |
GERN | C | -1.26% | |
LYEL | F | -1.25% | |
CGEM | F | -1.24% | |
SDGR | F | -1.23% | |
RAPT | D | -1.23% | |
ERAS | C | -1.23% | |
ZNTL | D | -1.22% | |
BNTX | B | -1.21% | |
IPHA | D | -1.18% | |
GLUE | A | -1.17% | |
LEGN | F | -1.16% | |
GMAB | F | -1.15% | |
NUVL | D | -1.13% | |
FHTX | C | -1.11% | |
KURA | F | -1.1% | |
SWTX | D | -1.09% | |
IDYA | F | -1.08% | |
RLAY | F | -1.05% | |
FATE | F | -1.03% | |
IMRX | D | -1.02% | |
NUVB | F | -1.02% | |
ITOS | F | -0.99% | |
IMTX | F | -0.99% | |
VOR | D | -0.94% | |
SMMT | C | -0.92% | |
PRLD | F | -0.85% |
MEDX: Top Represented Industries & Keywords
CNCR: Top Represented Industries & Keywords